ID   SORL_RAT                Reviewed;        2215 AA.
AC   P0DSP1;
DT   31-JUL-2019, integrated into UniProtKB/Swiss-Prot.
DT   31-JUL-2019, sequence version 1.
DT   24-JUL-2024, entry version 22.
DE   RecName: Full=Sortilin-related receptor;
DE   AltName: Full=Low-density lipoprotein receptor relative with 11 ligand-binding repeats;
DE            Short=LDLR relative with 11 ligand-binding repeats;
DE            Short=LR11;
DE   AltName: Full=Sorting protein-related receptor containing LDLR class A repeats;
DE            Short=SorLA;
DE   Flags: Precursor;
GN   Name=Sorl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9510025; DOI=10.1016/s0925-4773(97)00177-9;
RA   Hermans-Borgmeyer I., Hampe W., Schinke B., Methner A., Nykjaer A.,
RA   Suesens U., Fenger U., Herbarth B., Schaller H.C.;
RT   "Unique expression pattern of a novel mosaic receptor in the developing
RT   cerebral cortex.";
RL   Mech. Dev. 70:65-76(1998).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=17332490; DOI=10.1161/atvbaha.106.137091;
RA   Ohwaki K., Bujo H., Jiang M., Yamazaki H., Schneider W.J., Saito Y.;
RT   "A secreted soluble form of LR11, specifically expressed in intimal smooth
RT   muscle cells, accelerates formation of lipid-laden macrophages.";
RL   Arterioscler. Thromb. Vasc. Biol. 27:1050-1056(2007).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH GDNF.
RX   PubMed=21994944; DOI=10.1074/jbc.m111.246413;
RA   Geng Z., Xu F.Y., Huang S.H., Chen Z.Y.;
RT   "Sorting protein-related receptor SorLA controls regulated secretion of
RT   glial cell line-derived neurotrophic factor.";
RL   J. Biol. Chem. 286:41871-41882(2011).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH GFRA1.
RX   PubMed=23333276; DOI=10.1016/j.celrep.2012.12.011;
RA   Glerup S., Lume M., Olsen D., Nyengaard J.R., Vaegter C.B., Gustafsen C.,
RA   Christensen E.I., Kjolby M., Hay-Schmidt A., Bender D., Madsen P.,
RA   Saarma M., Nykjaer A., Petersen C.M.;
RT   "SorLA controls neurotrophic activity by sorting of GDNF and its receptors
RT   GFRalpha1 and RET.";
RL   Cell Rep. 3:186-199(2013).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH PPP3CB.
RX   PubMed=25967121; DOI=10.1681/asn.2014070728;
RA   Borschewski A., Himmerkus N., Boldt C., Blankenstein K.I., McCormick J.A.,
RA   Lazelle R., Willnow T.E., Jankowski V., Plain A., Bleich M., Ellison D.H.,
RA   Bachmann S., Mutig K.;
RT   "Calcineurin and sorting-related receptor with A-type repeats interact to
RT   regulate the renal Na(+)-K(+)-2Cl(-) cotransporter.";
RL   J. Am. Soc. Nephrol. 27:107-119(2016).
CC   -!- FUNCTION: Sorting receptor that directs several proteins to their
CC       correct location within the cell. Along with AP-1 complex, involved
CC       Golgi apparatus - endosome sorting. Sorting receptor for APP,
CC       regulating its intracellular trafficking and processing into
CC       amyloidogenic-beta peptides. Retains APP in the trans-Golgi network,
CC       hence preventing its transit through late endosomes where amyloid beta
CC       peptides Abeta40 and Abeta42 are generated. May also sort newly
CC       produced amyloid-beta peptides to lysosomes for catabolism. Does not
CC       affect APP trafficking from the endoplasmic reticulum to Golgi
CC       compartments. Sorting receptor for the BDNF receptor NTRK2/TRKB that
CC       facilitates NTRK2 trafficking between synaptic plasma membranes,
CC       postsynaptic densities and cell soma, hence positively regulates BDNF
CC       signaling by controlling the intracellular location of its receptor (By
CC       similarity). Sorting receptor for GDNF that promotes GDNF regulated,
CC       but not constitutive secretion (PubMed:21994944). Sorting receptor for
CC       the GDNF-GFRA1 complex, directing it from the cell surface to
CC       endosomes. GDNF is then targeted to lysosomes and degraded, while its
CC       receptor GFRA1 recycles back to the cell membrane, resulting in a GDNF
CC       clearance pathway. The SORL1-GFRA1 complex further targets RET for
CC       endocytosis, but not for degradation, affecting GDNF-induced
CC       neurotrophic activities (PubMed:23333276). Sorting receptor for
CC       ERBB2/HER2. Regulates ERBB2 subcellular distribution by promoting its
CC       recycling after internalization from endosomes back to the plasma
CC       membrane, hence stimulating phosphoinositide 3-kinase (PI3K)-dependent
CC       ERBB2 signaling (By similarity). Sorting receptor for lipoprotein
CC       lipase LPL. Promotes LPL localization to endosomes and later to the
CC       lysosomes, leading to degradation of newly synthesized LPL. Potential
CC       sorting receptor for APOA5, inducing APOA5 internalization to early
CC       endosomes, then to late endosomes, wherefrom a portion is sent to
CC       lysosomes and degradation, another portion is sorted to the trans-Golgi
CC       network. Sorting receptor for the insulin receptor INSR. Promotes
CC       recycling of internalized INSR via the Golgi apparatus back to the cell
CC       surface, thereby preventing lysosomal INSR catabolism, increasing INSR
CC       cell surface expression and strengthening insulin signal reception in
CC       adipose tissue. Does not affect INSR internalization (By similarity).
CC       Plays a role in renal ion homeostasis, controlling the phospho-
CC       regulation of SLC12A1/NKCC2 by STK39/SPAK kinase and PPP3CB/calcineurin
CC       A beta phosphatase, possibly through intracellular sorting of STK39 and
CC       PPP3CB (PubMed:25967121). Stimulates, via the N-terminal ectodomain,
CC       the proliferation and migration of smooth muscle cells, possibly by
CC       increasing cell surface expression of the urokinase receptor
CC       uPAR/PLAUR. This may promote extracellular matrix proteolysis and hence
CC       facilitate cell migration. By acting on the migration of intimal smooth
CC       muscle cells, may accelerate intimal thickening following vascular
CC       injury (By similarity). Stimulates proliferation and migration
CC       monocytes/macrophages. Through its action on intimal smooth muscle
CC       cells and macrophages, may accelerate intimal thickening and macrophage
CC       foam cell formation in the process of atherosclerosis (By similarity).
CC       Regulates hypoxia-enhanced adhesion of hematopoietic stem and
CC       progenitor cells to the bone marrow stromal cells via a PLAUR-mediated
CC       pathway. This function is mediated by the N-terminal ectodomain (By
CC       similarity). Metabolic regulator, which functions to maintain the
CC       adequate balance between lipid storage and oxidation in response to
CC       changing environmental conditions, such as temperature and diet. The N-
CC       terminal ectodomain negatively regulates adipose tissue energy
CC       expenditure, acting through the inhibition the BMP/Smad pathway (By
CC       similarity). May regulate signaling by the heterodimeric neurotrophic
CC       cytokine CLCF1-CRLF1 bound to the CNTFR receptor by promoting the
CC       endocytosis of the tripartite complex CLCF1-CRLF1-CNTFR and lysosomal
CC       degradation. Might regulate IL6 signaling, decreasing cis signaling,
CC       while up-regulating trans signaling (By similarity).
CC       {ECO:0000250|UniProtKB:O88307, ECO:0000250|UniProtKB:Q92673,
CC       ECO:0000269|PubMed:21994944, ECO:0000269|PubMed:23333276,
CC       ECO:0000269|PubMed:25967121}.
CC   -!- SUBUNIT: After maturation cleavage, interacts (via N-terminus) with its
CC       own propeptide; this interaction prevents interaction with other
CC       ligands, including CRLF1, GDNF, GFRA1, IL6 and IL6R. Interacts (via N-
CC       terminal ectodomain) with APP, forming a 1:1 stoichiometric complex,
CC       including with isoforms APP695, APP751 and APP770. Also interacts with
CC       APP C-terminal fragment C99 and with Abeta40. Interacts with beta-
CC       secretase BACE1/BACE; this interaction may affect BACE1-binding to APP
CC       and hence reduce BACE1-dependent APP cleavage. Interacts with
CC       LRPAP1/RAP. Interacts (via C-terminal cytosolic domain) with GGA1 and
CC       GGA2 (via N-terminal VHS domain). Interacts with PACS1. May interact
CC       (via the N-terminal ectodomain) with the morphogenetic neuropeptide,
CC       also called head activator or HA; this interaction is impaired in the
CC       presence of propeptide. Interacts with neurotensin/NTS. Interacts (via
CC       the N-terminal ectodomain) with PDGFB homodimer. Interacts (via N-
CC       terminal ectodomain) with the uPA receptor PLAUR. Interacts with
CC       uPA/PLAU and PAI1/SERPINE1, either individually or in complex with each
CC       other, leading to endocytosis. Also interacts with PAI1/SERPINE1 in
CC       complex with tPA/PLAT. Interacts (via C-terminus) with AP-1 and AP-2
CC       complexes (By similarity). Interacts with BMPR1A and BMPR1B (By
CC       similarity). Interacts with lipoprotein lipase LPL; this interaction is
CC       optimal in slightly acidic conditions (By similarity). Interacts (via
CC       N-terminal ectodomain) with GDNF (via propeptide) and GDNF receptor
CC       alpha-1/GFRA1, either individually or in complex with each other
CC       (PubMed:21994944, PubMed:23333276). Also interacts with other GDNF
CC       receptor alpha family members, including GFRA2, GFRA3 and GFRA4.
CC       Interacts with the insulin receptor INSR; this interaction strongly
CC       increases the surface exposure of INSR. Interacts (via cytosolic C-
CC       terminus) with STK39/SPAK. Interacts (via N-terminal ectodomain) with
CC       the heterodimeric complex CRLF1-CLC; within this complex, the
CC       interaction is mediated predominantly by the CRLF1 moiety. Interacts
CC       with CNTFR, as well as with the tripartite signaling complex formed by
CC       CRLF1, CLC and CNTFR. Interacts (via N-terminal ectodomain) with IL6;
CC       this interaction leads to IL6 internalization and lysosomal
CC       degradation. Binding of SOLRL1 secreted N-terminal ectodomain to IL6
CC       may increase IL6 trans signaling. Interacts with secreted IL6R; this
CC       interaction leads to IL6R internalization. Also interacts with
CC       transmembrane IL6R; this interaction does not seem to affect
CC       subcellular location. Interacts with APOE (By similarity). Interacts
CC       with apolipoprotein E-rich beta-VLDL (By similarity). Interacts with
CC       APOA5; this interaction leads to APOA5 internalization and is abolished
CC       by heparin. Interaction with APOA5 results in enhanced binding to
CC       chylomicrons. Interacts with ROCK2 (By similarity). Interacts (via
CC       cytosolic C-terminus) with PPP3CB/calcineurin A beta (PubMed:25967121).
CC       Interacts with NTRK2/TRKB (By similarity). Interacts (via cytosolic C-
CC       terminus) with HSPA12A in an ADP-dependent manner; this interaction
CC       affects SORL1 internalization and subcellular localization (By
CC       similarity). Interacts (via N-terminal ectodomain) with ERBB2/HER2 (By
CC       similarity). {ECO:0000250|UniProtKB:O88307,
CC       ECO:0000250|UniProtKB:Q92673, ECO:0000250|UniProtKB:Q95209,
CC       ECO:0000269|PubMed:21994944, ECO:0000269|PubMed:23333276,
CC       ECO:0000269|PubMed:25967121}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Golgi apparatus, trans-Golgi network
CC       membrane {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:Q92673}. Endosome membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Recycling endosome membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Endosome, multivesicular body membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q92673}. Cytoplasmic vesicle, secretory vesicle
CC       membrane {ECO:0000250|UniProtKB:Q92673}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:Q92673}. Secreted
CC       {ECO:0000250|UniProtKB:Q92673}. Note=Mostly intracellular,
CC       predominantly in the trans-Golgi network (TGN) and in endosome, as well
CC       as in endosome-to-TGN recycling compartments; found at low levels on
CC       the plasma membrane. At the cell surface, partially subjected to
CC       proteolytic shedding that releases the ectodomain (also called soluble
CC       SORLA, solLR11 or sLR11) in the extracellular milieu. The shedding may
CC       be catalyzed by ADAM17/TACE. Following shedding, PSEN1/presenilin-1
CC       cleaves the remaining transmembrane fragment and catalyzes the release
CC       of a C-terminal fragment in the cytosol and of a soluble N-terminal
CC       beta fragment in the extracellular milieu. The C-terminal cytosolic
CC       fragment localizes to the nucleus. At the cell surface, the full-length
CC       protein undergoes partial clathrin-dependent endocytosis guided by the
CC       clathrin adapter protein 2 (AP-2). {ECO:0000250|UniProtKB:Q92673}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the cerebral cortex, the
CC       pyramidal cells of the CA region of the hippocampus, the granular cells
CC       of the dentate gyrus, the Purkinje cell layer of the cerebellum and the
CC       piriform cortex. Lower levels were detected over the mitral cell layer
CC       of the olfactory bulb, the nuclei of the amygdala, the nucleus
CC       reticularis of the thalamus and several hypothalamic nuclei. In the
CC       brainstem weak expression in the pontine nuclei. In the central nervous
CC       system, expression is restricted to neurons (PubMed:9510025). Expressed
CC       in intimal smooth muscle cell after vascular injury (PubMed:17332490).
CC       {ECO:0000269|PubMed:17332490, ECO:0000269|PubMed:9510025}.
CC   -!- PTM: Within the Golgi apparatus, the propeptide may be cleaved off by
CC       FURIN or a furin-like protease. After cleavage, the propeptide
CC       interacts with the mature protein N-terminus, preventing the
CC       association with other ligands. At the cell surface, partially
CC       subjected to proteolytic shedding that releases the ectodomain in the
CC       extracellular milieu. The shedding may be catalyzed by ADAM17/TACE.
CC       Following shedding, PSEN1/presenilin-1 cleaves the remaining
CC       transmembrane fragment and catalyzes the release of a C-terminal
CC       fragment in the cytosol and of a soluble N-terminal beta fragment in
CC       the extracellular milieu. The C-terminal cytosolic fragment localizes
CC       to the nucleus. {ECO:0000250|UniProtKB:Q92673}.
CC   -!- PTM: Phosphorylation at Ser-2207 facilitates the interaction with GGA1.
CC       {ECO:0000250|UniProtKB:Q92673}.
CC   -!- SIMILARITY: Belongs to the VPS10-related sortilin family. SORL1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07070055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07070056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473975; EDL95248.1; -; Genomic_DNA.
DR   RefSeq; NP_445971.1; NM_053519.1.
DR   AlphaFoldDB; P0DSP1; -.
DR   SMR; P0DSP1; -.
DR   GlyCosmos; P0DSP1; 27 sites, No reported glycans.
DR   GlyGen; P0DSP1; 28 sites, 1 O-linked glycan (1 site).
DR   PhosphoSitePlus; P0DSP1; -.
DR   PaxDb; 10116-ENSRNOP00000056722; -.
DR   Ensembl; ENSRNOT00000095508.1; ENSRNOP00000089955.1; ENSRNOG00000064634.1.
DR   GeneID; 300652; -.
DR   KEGG; rno:300652; -.
DR   AGR; RGD:619914; -.
DR   CTD; 6653; -.
DR   RGD; 619914; Sorl1.
DR   GeneTree; ENSGT01030000234563; -.
DR   InParanoid; P0DSP1; -.
DR   OMA; LCPDGME; -.
DR   OrthoDB; 5840at2759; -.
DR   PRO; PR:P0DSP1; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Proteomes; UP000234681; Chromosome 8.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0031985; C:Golgi cisterna; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005771; C:multivesicular body; IDA:RGD.
DR   GO; GO:0032585; C:multivesicular body membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005641; C:nuclear envelope lumen; ISO:RGD.
DR   GO; GO:0097356; C:perinucleolar compartment; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0055037; C:recycling endosome; ISO:RGD.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005802; C:trans-Golgi network; ISO:RGD.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0019828; F:aspartic-type endopeptidase inhibitor activity; ISO:RGD.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; ISO:RGD.
DR   GO; GO:0042923; F:neuropeptide binding; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:RGD.
DR   GO; GO:1990845; P:adaptive thermogenesis; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0002024; P:diet induced thermogenesis; ISO:RGD.
DR   GO; GO:0099638; P:endosome to plasma membrane protein transport; ISO:RGD.
DR   GO; GO:0038020; P:insulin receptor recycling; ISO:RGD.
DR   GO; GO:1902992; P:negative regulation of amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; ISO:RGD.
DR   GO; GO:1902997; P:negative regulation of neurofibrillary tangle assembly; ISO:RGD.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISO:RGD.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0010897; P:negative regulation of triglyceride catabolic process; ISO:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISO:RGD.
DR   GO; GO:1904179; P:positive regulation of adipose tissue development; ISO:RGD.
DR   GO; GO:1902955; P:positive regulation of early endosome to recycling endosome transport; ISO:RGD.
DR   GO; GO:2001137; P:positive regulation of endocytic recycling; ISO:RGD.
DR   GO; GO:1902953; P:positive regulation of ER to Golgi vesicle-mediated transport; ISO:RGD.
DR   GO; GO:1900168; P:positive regulation of glial cell-derived neurotrophic factor production; ISO:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; ISO:RGD.
DR   GO; GO:1902966; P:positive regulation of protein localization to early endosome; ISO:RGD.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; ISO:RGD.
DR   GO; GO:0034067; P:protein localization to Golgi apparatus; ISO:RGD.
DR   GO; GO:0051604; P:protein maturation; ISO:RGD.
DR   GO; GO:0045053; P:protein retention in Golgi apparatus; ISO:RGD.
DR   GO; GO:0006605; P:protein targeting; ISO:RGD.
DR   GO; GO:0006622; P:protein targeting to lysosome; ISO:RGD.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0014910; P:regulation of smooth muscle cell migration; ISO:RGD.
DR   CDD; cd00063; FN3; 5.
DR   CDD; cd00112; LDLa; 11.
DR   Gene3D; 2.10.70.80; -; 1.
DR   Gene3D; 3.30.60.270; -; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 4.
DR   Gene3D; 4.10.400.10; Low-density Lipoprotein Receptor; 11.
DR   Gene3D; 2.120.10.30; TolB, C-terminal domain; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR000033; LDLR_classB_rpt.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR031777; Sortilin_C.
DR   InterPro; IPR031778; Sortilin_N.
DR   InterPro; IPR006581; VPS10.
DR   InterPro; IPR050310; VPS10-sortilin.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR12106; SORTILIN RELATED; 1.
DR   PANTHER; PTHR12106:SF20; SORTILIN-RELATED RECEPTOR; 1.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF00057; Ldl_recept_a; 10.
DR   Pfam; PF00058; Ldl_recept_b; 2.
DR   Pfam; PF15902; Sortilin-Vps10; 1.
DR   Pfam; PF15901; Sortilin_C; 1.
DR   PRINTS; PR00261; LDLRECEPTOR.
DR   SMART; SM00060; FN3; 6.
DR   SMART; SM00192; LDLa; 11.
DR   SMART; SM00135; LY; 5.
DR   SMART; SM00602; VPS10; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 3.
DR   SUPFAM; SSF57424; LDL receptor-like module; 11.
DR   SUPFAM; SSF110296; Oligoxyloglucan reducing end-specific cellobiohydrolase; 1.
DR   SUPFAM; SSF63825; YWTD domain; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS01209; LDLRA_1; 10.
DR   PROSITE; PS50068; LDLRA_2; 11.
DR   PROSITE; PS51120; LDLRB; 4.
PE   1: Evidence at protein level;
KW   Cell membrane; Cleavage on pair of basic residues; Cytoplasmic vesicle;
KW   Developmental protein; Disulfide bond; EGF-like domain; Endocytosis;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   PROPEP          29..81
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT                   /id="PRO_0000447670"
FT   CHAIN           82..2215
FT                   /note="Sortilin-related receptor"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000447671"
FT   TOPO_DOM        29..2138
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2139..2159
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2160..2215
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          136..147
FT                   /note="BNR 1"
FT   REPEAT          232..243
FT                   /note="BNR 2"
FT   REPEAT          441..452
FT                   /note="BNR 3"
FT   REPEAT          521..532
FT                   /note="BNR 4"
FT   REPEAT          562..573
FT                   /note="BNR 5"
FT   REPEAT          800..843
FT                   /note="LDL-receptor class B 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00461"
FT   REPEAT          844..887
FT                   /note="LDL-receptor class B 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00461"
FT   REPEAT          888..930
FT                   /note="LDL-receptor class B 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00461"
FT   REPEAT          931..972
FT                   /note="LDL-receptor class B 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00461"
FT   DOMAIN          1026..1072
FT                   /note="EGF-like"
FT   DOMAIN          1077..1113
FT                   /note="LDL-receptor class A 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1116..1154
FT                   /note="LDL-receptor class A 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1157..1193
FT                   /note="LDL-receptor class A 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1198..1236
FT                   /note="LDL-receptor class A 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1234..1272
FT                   /note="LDL-receptor class A 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1274..1316
FT                   /note="LDL-receptor class A 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1324..1360
FT                   /note="LDL-receptor class A 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1367..1404
FT                   /note="LDL-receptor class A 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1418..1454
FT                   /note="LDL-receptor class A 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1470..1507
FT                   /note="LDL-receptor class A 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1513..1550
FT                   /note="LDL-receptor class A 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          1557..1649
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1653..1745
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1747..1843
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1844..1928
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1935..2030
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          2191..2215
FT                   /note="Required for efficient Golgi apparatus - endosome
FT                   sorting"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   REGION          2202..2215
FT                   /note="Required for interaction with GGA1 and GGA2"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   MOTIF           63..65
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           2162..2165
FT                   /note="Potential nuclear localization signal for the C-
FT                   terminal fragment generated by PSEN1"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   MOTIF           2173..2178
FT                   /note="Endocytosis signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           2209..2213
FT                   /note="DXXLL motif involved in the interaction with GGA1"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   MOD_RES         114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   MOD_RES         2207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   CARBOHYD        99
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   CARBOHYD        158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        368
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        430
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        616
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        674
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        818
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        871
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1035
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1068
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1191
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1367
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1458
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1608
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1706
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1733
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   CARBOHYD        1810
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1855
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1895
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1987
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2011
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   CARBOHYD        2055
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2070
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2077
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   CARBOHYD        2093
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92673"
FT   DISULFID        1078..1090
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1085..1103
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1097..1112
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1117..1131
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1125..1144
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1138..1153
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1158..1170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1165..1183
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1177..1192
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1199..1211
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1206..1224
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1218..1235
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1235..1249
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1244..1262
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1256..1271
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1275..1289
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1283..1302
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1296..1315
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1325..1337
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1332..1350
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1344..1359
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1368..1381
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1376..1394
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1388..1403
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1419..1431
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1426..1444
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1438..1453
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1471..1484
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1478..1497
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1491..1506
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1514..1527
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1521..1540
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DISULFID        1534..1549
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
SQ   SEQUENCE   2215 AA;  247316 MW;  4D9A196919A5C406 CRC64;
     MATRSSRRES RLPFLFTLVA LLPPGALGGG WTQRLHGGGA PLPQDRGFFV VQGDPHELRL
     GTHGDAWGAS PAARKPLRTR RSAALQPQPI QVYGQVSLND SHNQMVVHWA GEKSNVIVAL
     ARDSLALTRP KSSDVYVSYD YGKSFNKISE KLNFGVGNSS EAVISQFYHS PADNKRYIFV
     DAYARYLWIT FDFGSTIHGF SIPFRAADLL LHSKASNLLL GFDSSHPNKQ LWKSDDFGQT
     WIMIQEHVKS FSWGIDPYDQ PNTIYIERHE PFGFSTVFRS TDFFQSRENQ EVILEEVRDF
     QLRDKYLFAT KVVHLPGSQQ QSSVQLWVSF GRKPMRAAQF VTKHPINEYY IADASEDQVF
     VCVSHSNNST NLYISEAEGL KFSLSLENVL YYSPGGAGSD TLVRYFANEP FADFHRVEGL
     QGVYIATLIN GSMSEENMRS VITFDKGGTW EFLQAPAFTG YGEKINCELS QGCSLHLAQR
     LSQLLNLQLR RMPILSKESA PGLIIATGSV GKNLASKTNV YISSSAGARW REALPGPHYY
     TWGDHGGIIM AIAQGMETNE LKYSTNEGET WKTFVFSEKP VFVYGLLTEP GEKSTVFTIF
     GSNKESVHSW LILQVNATDA LGVPCTENDY KLWSPSDERG NECLLGHKTV FKRRTPHATC
     FNGEDFDRPV VVSNCSCTRE DYECDFGFKM SEDISLEVCV PDPEFSGKPY SPPVPCPVGS
     SYRRTRGYRK ISGDTCSGGD VEARLEGELV PCPLAEENEF ILYAMRKSIY RYDLASGATE
     QLPLSGLRAA VALDFDYEHN CLYWSDLALD TIQRLCLNGS TGQEVIINSG LETVEALAFE
     PLSQLLYWVD AGFKKIEVAN PDGDFRLTIV NSSVLDRPRA LVLVPQEGVM FWTDWGDLKP
     GIYRSNMDGS AAYRLVSEDV KWPNGISVDG HWIYWTDAYL DCIERITFSG QQRSVILDNL
     PHPYAIAVFK NEIYWDDWSQ LSIFRASKYS RSQVETLASQ LTGLMDMKIF YKGKNAGSNA
     CIPQPCSLLC LPKANNSKSC RCPEGVASSV LPSGYLMCDC PQGYERKNNT CVKEENTCLR
     NQYHCSNGNC INSIWWCDFD NDCGDMSDER NCPTTICDAD TQFRCQESGT CIPLSYKCDL
     EDDCGDNSDE SHCEMHQCRS DEFNCSSGMC IRSSWVCDGD NDCRDWSDEA NCTAIYHTCE
     ASNFQCHNGH CIPQRWACDG DADCQDGSDE DPISCEKKCN GFHCPNGTCI PSSKHCDGLR
     DCPDGSDEQH CEPFCTRFMD FVCKNRQQCL FHSMVCDGII QCRDGSDEDA TFAGCSQDPE
     FHKECDEFGF QCQNGVCISL IWKCDGMDDC GDYSDEANCE NPTEAPNCSR YFQFHCENGR
     CIPNRWKCDR ENDCGDWSDE KDCGDSHIFP SPTPGPSTCL PNYFRCSSGA CVMGTWVCDG
     YRDCADGSDE EACPSLANST AASTPTQLGQ CDRFEFECRQ PKKCIPNWKR CDGHQDCQDG
     QDEANCPTHS TLTCMSREFK CEDGEACIVL SERCDGFLDC SDESDEKACS DELTVYKVQN
     LQWIADFSGD VTLTWTRPKK MPSASCVYNV YYRVVGESIW KTLETHSNKT STVLKVLKPD
     TTYQVKVQVH CLSKVHNTND FVTLRTPEGL PDAPRNLQLS LNSEEEGVIL GHWAPPVHTH
     GLIREYIVEY SRSGSKMWAS QRAASNSTEI KNLLLNALYT VRVAAVTSRG IGNWSDSKSI
     TTTKGKVIQA PNIHIDSYDE NSLSFTLTMD GDIKVNGYVV NLFWSFDAHK QEKKTLNFRG
     GSSLSHKVSN LTAHTSYEVS AWAKTDLGDS PLAFEHILTR GISPPAPSLK AKAINQTAVE
     CIWTGPKNVV YGIFYATSFL DLYRNPKSLT TSLHNKTVIV SKDEQYLFLV RVLIPYQGPS
     SDYVVVKMIP DSRLPPRHLH AVQIGKTSAV IKWESPYDSP DQDLFYAIAV KDLIRKTDRS
     YKVRSRNSTV EYSLSKLEPG GKYHIIVQLG NMSKDSSIKI TTVSLSAPDA LKIITENDHV
     LLFWKSLALK EKQFNETRGY EIHMFDSAVN LTAYLGNTTD NFFKVSNLKM GHNYTFTVQA
     RCLFGSQICG EPAVLLYDEL SSGGDATVVQ TARSTDVAAV VVPILFLILL SLGVGFAVLY
     TKHRRLQSSF TAFANSHYSS RLGSAIFSSG DDLGEDDEDA PMITGFSDDV PMVIA
//
